Spots Global Cancer Trial Database for breast inflammatory carcinoma
Every month we try and update this database with for breast inflammatory carcinoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Panitumumab and Pembrolizumab in Combination With Neoadjuvant Chemotherapy for the Treatment of Stage III-IV Triple Negative Breast Cancer | NCT05177796 | Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Breast Inflamma... Invasive Breast... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Triple-Negative... | Carboplatin Cyclophosphamid... Doxorubicin Paclitaxel Panitumumab Pembrolizumab | 18 Years - | M.D. Anderson Cancer Center | |
| Pembrolizumab in Treating Patients With Hormone Receptor Positive, Localized Inflammatory Breast Cancer Who Are Receiving Hormone Therapy and Did Not Achieve a Pathological Complete Response to Chemotherapy | NCT02971748 | Anatomic Stage ... Anatomic Stage ... Breast Inflamma... Prognostic Stag... Prognostic Stag... | Pembrolizumab | 18 Years - | M.D. Anderson Cancer Center | |
| Radiation Therapy With or Without Olaparib in Treating Patients With Inflammatory Breast Cancer | NCT03598257 | Breast Inflamma... | Biospecimen Col... Olaparib Radiation Thera... Survey Administ... | 18 Years - | National Cancer Institute (NCI) | |
| Grapiprant and Eribulin for the Treatment of Metastatic Inflammatory Breast Cancer | NCT05041101 | Breast Inflamma... Recurrent Breas... Stage IV Breast... | Eribulin Mesyla... Grapiprant | 18 Years - | M.D. Anderson Cancer Center | |
| Grapiprant and Eribulin for the Treatment of Metastatic Inflammatory Breast Cancer | NCT05041101 | Breast Inflamma... Recurrent Breas... Stage IV Breast... | Eribulin Mesyla... Grapiprant | 18 Years - | M.D. Anderson Cancer Center | |
| Multi-epitope Folate Receptor Alpha Peptide Vaccine, GM-CSF, and Cyclophosphamide in Treating Patients With Triple Negative Breast Cancer | NCT03012100 | Bilateral Breas... Breast Inflamma... Stage IB Breast... Stage II Breast... Stage IIA Breas... Stage IIB Breas... Stage III Breas... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea... Triple-Negative... Unilateral Brea... | Cyclophosphamid... Laboratory Biom... Multi-epitope F... Placebo Adminis... Sargramostim | 18 Years - | Academic and Community Cancer Research United | |
| Panitumumab and Pembrolizumab in Combination With Neoadjuvant Chemotherapy for the Treatment of Stage III-IV Triple Negative Breast Cancer | NCT05177796 | Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Breast Inflamma... Invasive Breast... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Triple-Negative... | Carboplatin Cyclophosphamid... Doxorubicin Paclitaxel Panitumumab Pembrolizumab | 18 Years - | M.D. Anderson Cancer Center | |
| Radiation Therapy With or Without Olaparib in Treating Patients With Inflammatory Breast Cancer | NCT03598257 | Breast Inflamma... | Biospecimen Col... Olaparib Radiation Thera... Survey Administ... | 18 Years - | National Cancer Institute (NCI) | |
| Neratinib and Paclitaxel With or Without Pertuzumab and Trastuzumab Before Combination Chemotherapy in Treating Patients With Metastatic or Locally Advanced Breast Cancer | NCT03101748 | Breast Inflamma... Locally Advance... Metastatic Brea... Stage III Breas... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea... Stage IV Breast... | Cyclophosphamid... Doxorubicin Laboratory Biom... Neratinib Paclitaxel Pertuzumab Trastuzumab | 18 Years - | M.D. Anderson Cancer Center | |
| Lymphovenous Bypass Procedure Before Underarm Lymph Node Surgery in Preventing Lymphedema in Patients With Inflammatory or Locally Advanced Non-inflammatory Breast Cancer or Melanoma | NCT03941756 | Anatomic Stage ... Breast Inflamma... Locally Advance... Melanoma | Indocyanine Gre... Lymphangiograph... Lymphovenous By... | 18 Years - | M.D. Anderson Cancer Center | |
| Grapiprant and Eribulin for the Treatment of Metastatic Inflammatory Breast Cancer | NCT05041101 | Breast Inflamma... Recurrent Breas... Stage IV Breast... | Eribulin Mesyla... Grapiprant | 18 Years - | M.D. Anderson Cancer Center |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
